Doximity, Inc.
DOCS Healthcare Health Information Services
Doximity, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $644.9 million, up 13.1% from fiscal 2025.
- Revenue
- +3.57%
- EPS
- −42.4%
- Free cash flow
- +1.87%
Quarter to September 2026, against a year earlier
Follow DOCS
Alert me
Doximity, Inc. (DOCS) EV/FCF
As of 5 November 2026, Doximity, Inc. (DOCS) trades at a EV/FCF of 17.7×. Over the past ten years it has ranged from −878× (September 2024) to 139× (October 2021); the current reading is higher than 19% of that period.
EV/FCF, daily
Embed this chart
Annual newest first
| Period | EV/FCF | Change |
|---|---|---|
| FY2026 | 11.4× | (69.46%) |
| FY2025 | 37.2× | 55.77% |
| FY2024 | 23.9× | (23.48%) |
| FY2023 | 31.2× | (51.10%) |
| FY2022 | 63.8× | 31.75% |
| FY2021 | 48.5× | 0.00% |
| FY2020 | 48.5× | 0.00% |
| FY2019 | 48.5× | — |
Quarterly newest first
| Period | EV/FCF | Change |
|---|---|---|
| Sep 2026 | 14.7× | 40.71% |
| Jun 2026 | 10.4× | (8.20%) |
| Mar 2026 | 11.4× | (53.85%) |
| Dec 2025 | 24.6× | (40.20%) |
| 23 more quarters | Free account |
Against its own ten years
EV/FCF against peers
| Company | EV/FCF |
|---|---|
| TEM Tempus AI, Inc. compare | −89.6× |
| HTFL Heartflow, Inc. compare | −76.6× |
| SDGR Schrodinger, Inc. compare | −15.4× |
| DOCS Doximity, Inc. | 17.7× |
| HQY HealthEquity, Inc. compare | 21.2× |
| PRVA Privia Health Group, Inc. compare | 24.3× |
| WAY Waystar Holding Corp. compare | 25.3× |
| BTSG BrightSpring Health Services, Inc. compare | 30.7× |
| HNGE Hinge Health Inc. compare | 30.9× |
What EV/FCF is
EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))
More on DOCS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement